Skip to main content
CYH
NYSE Life Sciences

CYH Continues Divestiture Strategy as Freeman Health System Acquires Northwest Health

Reported by Dow Jones Newswires
Sentiment info
Positive
Importance info
7
Price
$2.715
Mkt Cap
$382.59M
52W Low
$2.385
52W High
$4.43
Market data snapshot near publication time

Summary

Freeman Health System has completed the acquisition of Northwest Health. This transaction is likely a divestiture by Community Health Systems (CYH), aligning with its ongoing strategy to sell non-core assets and reduce its significant debt load. This follows previous hospital sales and a recent tender offer for $600 million in senior secured notes. Divestitures are critical for CYH to improve its balance sheet and financial flexibility, especially after reporting a net loss and negative operating cash flow in Q1 2026.

At the time of this announcement, CYH was trading at $2.72 on NYSE in the Life Sciences sector, with a market capitalization of approximately $382.6M. The 52-week trading range was $2.39 to $4.43. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

CYH - Latest Insights

CYH
Jun 01, 2026, 11:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
CYH
May 06, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
9
CYH
Apr 22, 2026, 8:20 PM EDT
Filing Type: 8-K
Importance Score:
8
CYH
Apr 22, 2026, 7:11 PM EDT
Source: Reuters
Importance Score:
9
CYH
Apr 22, 2026, 4:30 PM EDT
Filing Type: 10-Q
Importance Score:
9
CYH
Apr 21, 2026, 4:35 PM EDT
Filing Type: 8-K
Importance Score:
8
CYH
Apr 21, 2026, 4:26 PM EDT
Source: Reuters
Importance Score:
7
CYH
Apr 02, 2026, 4:30 PM EDT
Filing Type: DEF 14A
Importance Score:
8
CYH
Apr 01, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
9
CYH
Mar 05, 2026, 5:00 PM EST
Filing Type: 8-K
Importance Score:
8